標題：
1、January 8, 1982
Cough Variant Asthma in Children
Paul J. Hannaway, MD; G. David K. Hopper, MD
JAMA. 1982;247(2):206-208. doi:10.1001/jama.1982.03320270044023
2、J Dig Dis. 2018 Feb 1. doi: 10.1111/1751-2980.12583. [Epub ahead of print]
Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial.
3、Brexit from current guideline recommendations
4、Tolvaptan in Chinese cirrhotic patients with ascites: a randomized, placebo-controlled phase 2 trial
5、Increased serum c-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tovaptan in patients with
liver cirrhosis
6、In vitro p-glycoproten interactions and steady-state pharmacokinetic interactions between tolvaptan and digoxin in healthy subjects.
7、Pharmacokinetics and pharmacodynamics interaction between tolvaptan and warfarin in healthy subjects
8、Absolute bioavailability of tolvaptan and determination of minimally effective concentrations in healthy subjects
9、7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoy-amino)benzoy]-2,3,4,5-tetrahydro-1H-1-benzazepine(OPC-41061): a potent, orally active nonpeptide arginine vasorpressin V2 receptor antagonist
10:33:17
[更多]
